20-hydroxy-5,8,11,14-eicosatetraenoic acid has been researched along with Cirrhosis in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hasegawa, Y; Hirata, T; Inatani, S; Kojima, N; Koretsune, H; Ohara, H; Takahashi, T | 1 |
| Ito, D; Ito, O; Kohzuki, M; Miura, T; Muroya, Y; Ogawa, Y; Sakuyama, A; Takahashi, J; Xu, L | 1 |
| Booz, GW; Fan, F; He, X; Wang, S; Yu, Q; Zhang, C | 1 |
| Arad, M; Hochhauser, E; Peterson, SJ; Waldman, M | 1 |
2 review(s) available for 20-hydroxy-5,8,11,14-eicosatetraenoic acid and Cirrhosis
| Article | Year |
|---|---|
Conflicting roles of 20-HETE in hypertension and renal end organ damage.
Topics: Animals; Antihypertensive Agents; Arachidonic Acid; Cytochrome P-450 Enzyme System; Endothelium, Vascular; Fibrosis; Humans; Hydroxyeicosatetraenoic Acids; Hypertension; Kidney; Muscle, Smooth, Vascular; Peptidyl-Dipeptidase A; Polymorphism, Genetic; Receptors, G-Protein-Coupled; Renal Elimination; Renal Insufficiency; Renin-Angiotensin System; Sodium; Vascular Remodeling | 2018 |
The role of 20-HETE in cardiovascular diseases and its risk factors.
Topics: Animals; Cardiovascular Diseases; Coronary Vessels; Fibrosis; Humans; Hydroxyeicosatetraenoic Acids; Risk Factors | 2016 |
2 other study(ies) available for 20-hydroxy-5,8,11,14-eicosatetraenoic acid and Cirrhosis
| Article | Year |
|---|---|
Renoprotective Effect of TP0472993, a Novel and Selective 20-Hydroxyeicosatetraenoic Acid Synthesis Inhibitor, in Mouse Models of Renal Fibrosis.
Topics: Animals; Disease Models, Animal; Fibrosis; Kidney; Kidney Diseases; Mice; Mice, Inbred C57BL; Nephritis; Renal Insufficiency, Chronic; Ureteral Obstruction | 2023 |
Exercise training delays renal disorders with decreasing oxidative stress and increasing production of 20-hydroxyeicosatetraenoic acid in Dahl salt-sensitive rats.
Topics: Animals; Antihypertensive Agents; Arachidonic Acid; Blood Pressure; Fibrosis; Hydroxyeicosatetraenoic Acids; Hypertension; Kidney; Kidney Diseases; Male; Oxidative Stress; Physical Conditioning, Animal; Rats; Rats, Inbred Dahl; Sodium Chloride; Sodium Chloride, Dietary; Thiobarbituric Acid Reactive Substances | 2020 |